Fonadelpar (NPS-005) (Synonyms: NPS-005; SJP-0035) |
| Catalog No.GC33734 |
Fonadelpar (NPS-005) is a PPARδ agonist, used in the research of neuroparalytic keratopathy.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 515138-06-4
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Fonadelpar is a PPARδ agonist, used in the research of neuroparalytic keratopathy.
Fonadelpar is a PPARδ agonist, used in the research of neuroparalytic keratopathy[1].
[1]. Kobayashi, et al. Therapeutic agent for neuroparalytic keratopathy containing benzisoxazol compound-?based PPARδ agonist. WO2016199871A1.
Average Rating: 5 (Based on Reviews and 32 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *